
Releases
Embecta Investors Face Securities Litigation Over Misleading Guidance
Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, are being urged to join a class action lawsuit. The litigation claims the medical device company issued false fiscal projections while concealing significant operational hurdles within its core pen needle market.





















